[{"StockholdersEquityConverted_0_Q1_USD":3072100000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":149700000.0,"EarningsPerShareDiluted_1_Q1_USD":0.41,"CommonStockSharesOutstanding_0_Q1_shares":164567095.0,"StockholdersEquity_0_Q1_USD":3072100000.0,"Assets_0_Q1_USD":7984200000.0,"CommonStockSharesConverted_0_Q1_shares":164567095.0,"NetIncomeLossConverted_1_Q1_USD":68800000.0,"RevenuesConverted_1_Q1_USD":845700000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":166529038.0,"EarningsPerShareBasic_1_Q1_USD":0.42,"Ticker":"CTLT","CIK":"1596783","name":"CATALENT, INC.","OfficialName":"Catalent Inc. Common Stock","form":"10-Q","period":"20200930","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"17076283108.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"SP500","filed":"20201103"}]